These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8335338)

  • 1. [Effect of the humoral immune response on the pathogenesis of respiratory syncytial virus (RSV) infection].
    Streckert HJ; Humbert B; Philippou S; Forster J
    Immun Infekt; 1993 Jun; 21(3):75-7. PubMed ID: 8335338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants.
    Murphy BR; Collins PL; Lawrence L; Zubak J; Chanock RM; Prince GA
    J Gen Virol; 1989 Aug; 70 ( Pt 8)():2185-90. PubMed ID: 2671259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of respiratory syncytial virus-specific immune complexes in nasopharyngeal secretions following natural infection.
    Kaul TN; Welliver RC; Faden HS; Ogra PL
    J Clin Lab Immunol; 1984 Dec; 15(4):187-90. PubMed ID: 6527374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immune response to respiratory syncytial virus infection in owl monkeys.
    Koff WC; Caplan FR; Case S; Halstead SB
    Clin Exp Immunol; 1983 Aug; 53(2):272-80. PubMed ID: 6883807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique.
    Roca A; Abacassamo F; Loscertales MP; Quintó L; Gómez-Olivé X; Fenwick F; Saiz JC; Toms G; Alonso PL
    J Med Virol; 2002 Aug; 67(4):616-23. PubMed ID: 12116014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Respiratory syncytial virus and immune response: from the diagnosis of infection to prospects of vaccination].
    Pothier P
    Pediatrie; 1991; 46(8-9 Suppl):1-4. PubMed ID: 1665219
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoglobulin-class-specific immune response to respiratory syncytial virus structural proteins in infants, children, and adults.
    Popow-Kraupp T; Lakits E; Kellner G; Kunz C
    J Med Virol; 1989 Mar; 27(3):215-23. PubMed ID: 2723614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection.
    Welliver RC; Wong DT; Sun M; Middleton E; Vaughan RS; Ogra PL
    N Engl J Med; 1981 Oct; 305(15):841-6. PubMed ID: 6168908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The production of monoclonal antibodies against respiratory syncytial virus and its clinical applications.
    Wu B
    Clin Lab Med; 1985 Sep; 5(3):589-613. PubMed ID: 3899483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to respiratory syncytial virus polypeptides and their significance in human infection.
    Ward KA; Lambden PR; Ogilvie MM; Watt PJ
    J Gen Virol; 1983 Sep; 64 (Pt 9)():1867-76. PubMed ID: 6886679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characterization and uses of monoclonal antibodies to respiratory syncytial virus.
    Stott EJ; Bew MH; Taylor G; Jebbett J; Collins AP
    Dev Biol Stand; 1984; 57():237-44. PubMed ID: 6084614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent differences in cytokine and antibody responses after experimental RSV infection in a bovine model.
    Grell SN; Riber U; Tjørnehøj K; Larsen LE; Heegaard PM
    Vaccine; 2005 May; 23(26):3412-23. PubMed ID: 15837365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to respiratory syncytial virus: prevention of syncytia formation by human serum during in vitro infection.
    Faden H; Lin T; Hong JJ; Ogra PL
    Pediatr Res; 1984 Oct; 18(10):987-91. PubMed ID: 6387611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to respiratory syncytial virus structural proteins in children with acute respiratory syncytial virus infection.
    Vainionpää R; Meurman O; Sarkkinen H
    J Virol; 1985 Mar; 53(3):976-9. PubMed ID: 3973971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection.
    Chiba Y; Higashidate Y; Suga K; Honjo K; Tsutsumi H; Ogra PL
    J Med Virol; 1989 Jul; 28(3):133-9. PubMed ID: 2666570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus.
    Hendry RM; Burns JC; Walsh EE; Graham BS; Wright PF; Hemming VG; Rodriguez WJ; Kim HW; Prince GA; McIntosh K
    J Infect Dis; 1988 Apr; 157(4):640-7. PubMed ID: 3346563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections.
    Muelenaer PM; Henderson FW; Hemming VG; Walsh EE; Anderson LJ; Prince GA; Murphy BR
    J Infect Dis; 1991 Jul; 164(1):15-21. PubMed ID: 2056202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of breast feeding on the development of anti-idiotype antibody response to F glycoprotein of respiratory syncytial virus in infant mice after post-partum maternal immunization.
    Okamoto Y; Tsutsumi H; Kumar NS; Ogra PL
    J Immunol; 1989 Apr; 142(7):2507-12. PubMed ID: 2926142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to and frequency of reinfection with respiratory syncytial virus.
    Hall CB; Walsh EE; Long CE; Schnabel KC
    J Infect Dis; 1991 Apr; 163(4):693-8. PubMed ID: 2010624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory syncytial virus infection in Syrian hamsters. I. Development of humoral immunity.
    Skovikova LP; Taros LYu ; Volgarev AP
    Acta Virol; 1983 Nov; 27(6):490-5. PubMed ID: 6140834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.